1,149
Views
24
CrossRef citations to date
0
Altmetric
Author's View

Chronic inflammation in endometriosis and endometriosis-associated ovarian cancer: New roles for the “old” complement pathway

, &
Article: e1002732 | Received 22 Dec 2014, Accepted 23 Dec 2014, Published online: 21 May 2015

References

  • Sankaranarayanan R. Screening for cancer in low- and middle-income countries. Ann Glob Health 2014; 80:412–7; PMID:25512156; http://dx.doi.org/10.1016/j.aogh.2014.09.014
  • Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 2012; 13:385–94; PMID:22361336; http://dx.doi.org/10.1016/S1470-2045(11)70404-1
  • Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 1997; 30:249–55; PMID:9088954; http://dx.doi.org/10.1046/j.1365-2559.1997.d01-592.x
  • Funamizu A, Fukui A, Kamoi M, Fuchinoue K, Yokota M, Fukuhara R, Mizunuma H. Expression of natural cytotoxicity receptors on peritoneal fluid natural killer cell and cytokine production by peritoneal fluid natural killer cell in women with endometriosis. Am J Reprod Immunol 2014; 71:359–67; PMID:24495049; http://dx.doi.org/10.1111/aji.12206
  • Suryawanshi S, Huang X, Elishaev E, Budiu RA, Zhang L, Kim S, Donnellan N, Mantia-Smaldone G, Ma T, Tseng G, et al. Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res 2014; 20:6163–74; PMID:25294912; http://dx.doi.org/10.1158/1078-0432.CCR-14-1338
  • Budiu RA, Elishaev E, Brozick J, Lee M, Edwards RP, Kalinski P, Vlad AM. Immunobiology of human mucin 1 in a preclinical ovarian tumor model. Oncogene 2013; 32:3664–75; PMID:22964632; http://dx.doi.org/10.1038/onc.2012.397
  • Budiu RA, Diaconu I, Chrissluis R, Dricu A, Edwards RP, Vlad AM. A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells. Dis Model Mech 2009; 2:593–603; PMID:19841240; http://dx.doi.org/10.1242/dmm.002535
  • Pio R, Ajona D, Lambris JD. Complement inhibition in cancer therapy. Semin Immunol 2013; 25:54–64; PMID:23706991; http://dx.doi.org/10.1016/j.smim.2013.04.001
  • Rutkowski MJ, Sughrue ME, Kane AJ, Ahn BJ, Fang S, Parsa AT. The complement cascade as a mediator of tissue growth and regeneration. Inflamm Res 2010; 59:897–905; PMID:20517706; http://dx.doi.org/10.1007/s00011-010-0220-6
  • Suryawanshi S, Vlad AM, Lin HM, Mantia-Smaldone G, Laskey R, Lee M, Lin Y, Donnellan N, Klein-Patel M, Lee T, et al. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res 2013; 19:1213–24; PMID:23362326; http://dx.doi.org/10.1158/1078-0432.CCR-12-2726

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.